Sclerotherapy for hydrocele revisited: a prospective randomised study

Agrawal, M.; Yadav, H.; Upadhyay, A.; Jaiman, R.; Singhal, J.; Singh, A.
February 2009
Indian Journal of Surgery;Feb2009, Vol. 71 Issue 1, p23
Academic Journal
A prospective randomised trial to study the efficacy and safety of hydrocele sclerotherapy with phenol and polidocanol. Eighty-six patients with unilateral primary vaginal hydroceles were randomised into three groups: group 1 (phenol sclerotherapy) � 29 patients, group 2 (polidocanol sclerotherapy) � 29 patients and group 3 (operative treatment) � 28 patients. Sclerotherapy was performed on outpatient basis using either 5�10 ml of 5% phenol or 2�4 ml of 1% polidocanol, while patients in group 3 underwent surgical repair of hydrocele (Jaboulay�s procedure). Statistical analysis was performed using ANOVA. The cure rates in group 1, 2 and 3 were 96.5%, 51.7% and 100%, respectively. The pain scores (visual analogue scale) in group 1, 2 and 3 at 1 week and 1 month were 14.5 and 1.8; 10.1 and 1.3; 64.0 and 10.6, respectively. There was significant difference among the three groups in mean hospital stay (1.8, 1.5 and 9.7 hours, respectively) and time to work resumption (1.3, 1.1 and 12.7 days, respectively). Statistically significant differences in pain scores and complications were observed between sclerotherapy and operative groups. Five percent phenol is a better sclerosant than 1% polidocanol and is as efficacious as operative treatment, with lesser morbidity and similar safety profile.


Related Articles

  • Pharmacologic Management of Neuropsychiatric Symptoms of Alzheimer Disease. Herrmann, Nathan; Lanct�t, Krista L. // Canadian Journal of Psychiatry;Oct2007, Vol. 52 Issue 10, p630 

    Objective: To systematically review published clinical trials of the pharmacotherapy of neuropsychiatric symptoms of Alzheimer disease (AD). Method: We searched MEDLINE and EMBASE for published English-language medical literature. Our review focused on randomized controlled trials (RCTs) and...

  • Irinotecan/cisplatin versus Etoposide/cisplatin for Patients with Extensive Stage Small Cell Lung Cancer: A Systematic Review. Nan YAO; Lei JIANG; Kehu YANG; Yancheng YE; Denghai MI; Guangtao MIN // Chinese Journal of Lung Cancer;Aug2009, Vol. 12 Issue 8, p884 

    Background and objective It is unclear whether etoposide/cisplatin (EP) regimen is the optimal chemotherapy regimen in the treatment patients with extensive small cell lung cancer (SCLC), this study was aimed to evaluate the efficacy and safety of patients with extensive SCLC treated with...

  • Sclerotherapy vs. Hydrocelectomy.  // Fertility Weekly;4/21/2003, p15 

    Focuses on the efficiency of sclerotherapy as hydrocelectomy for the cure of hydrocele. Similarity of sclerotherapy and hydrocelectomy in terms of effects on spermatogenesis; Risk of complications arising from phenol sclerotherapy; Prevalence of statistical alteration in spermatozoid concentration.

  • Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis. Mitnick, Carole D.; Castro, Kenneth G.; Harrington, Mark; Sacks, Leonard V.; Burman, William // PLoS Medicine;Nov2007, Vol. 4 Issue 11, pe292 

    The time is now right for randomized trials of MDR-TB, say the authors, as the expansion of MDR-TB programs provides the setting in which trials can be implemented.

  • The power of nonspecific variables on health. Rakel, David P. // Patient Care;Mar2007, Vol. 41 Issue 3, p35 

    The article comments on the power of nonspecific variables on health. The author said that randomized controlled trials (RCT) by design eliminate nonspecific variables in order to understand the power of the specific or intrinsic effect of the therapy under investigation. Despite the importance...

  • Impact of Baseline Disease Severity Over 26 and 52 Weeks of Treatment with Calcitriol Ointment 3�g/g in Patients with Mild-to-moderate Plaque Psoriasis. Lebwohl, Mark; Preston, Norman; Gottschalk, Ronald W. // Journal of Clinical & Aesthetic Dermatology;Feb2012, Vol. 5 Issue 2, p28 

    Objective: Calcitriol 3�g/g ointment has been shown to be a safe and effective treatment for adults with mild-tomoderate plaque psoriasis. This analysis evaluated the response to calcitriol 3�g/g ointment relative to baseline disease. Design: Retrospective analysis of data from a...

  • Randomized Controlled Trials-- an Indispensible Part of Clinical Research. Stang, Andreas // Deutsches Aerzteblatt International;9/30/2011, Vol. 108 Issue 39, p661 

    The author reflects on the advantages of randomized controlled trials (RCTs) over the non randomezised analysis in the evaluation of therapeutic procedure. He recommends for the randomized analysis which maintains a structural equivalence in the patient groups and which is also a main factor...

  • Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency. Mitsumori, Michihide; Zhi-Fan, Zeng; Oliynychenko, Praskovya; Park, Jeong Ho; Choi, Ihl Bohng; Tatsuzaki, Hideo; Tanaka, Yoshiaki; Hiraoka, Masahiro // International Journal of Clinical Oncology;Jun2007, Vol. 12 Issue 3, p192 

    An International Atomic Energy Agency (IAEA)-sponsored, multi-institutional prospective randomized trial was conducted to clarify whether the combination of hyperthermia and radiotherapy improves the local response rate of locally advanced non-small cell lung cancer (NSCLC) compared with that...

  • A simple method for analyzing data from a randomized trial with a missing binary outcome. Baker, Stuart G.; Freedman, Laurence S. // BMC Medical Research Methodology;2003, Vol. 3, p8 

    Background: Many randomized trials involve missing binary outcomes. Although many previous adjustments for missing binary outcomes have been proposed, none of these makes explicit use of randomization to bound the bias when the data are not missing at random. Methods: We propose a novel approach...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics